- Vapotherm Inc VAPO shares plunged almost 40% after the company reported disappointing Q3 FY22 earnings.
- Total revenue was $13.5 million, down 65% Y/Y and missing the consensus estimate of $16.54 million.
- Vapotherm reported a wider EPS loss of $(0.98) compared to $(0.52) a year ago and missing the Wall Street estimate of $(0.78).
- The company is evaluating various capital-raising options while it continues to execute its path-to-profitability initiative, which includes converting $20 million of excess inventory into cash.
- The company believes the combination of additional capital and converting up to $20 million of inventory into cash will allow it to fund its business through 2023 and get it to Adjusted EBITDA positive in Q4 of 2023.
- Guidance: For fiscal 2022, Vapotherm expects sales of $64-$66 million, down from prior guidance of $76-$81 million.
- The company says that the guidance reflects a light flu season and does not reflect any significant COVID impact.
- Vapotherm expects a gross margin of 22%-24%, a decrease from the previous range of 30%-32%.
- Price Action: VAPO shares are down 38.60% at $1.29 on the last check Thursday.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Posted In: EarningsNewsPenny StocksGuidanceHealth CareFinancingMoversTrading IdeasGeneralBriefswhy it's moving
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in